Law360, New York (July 13, 2009, 12:00 AM ET) -- American Capital Ltd. is seeking the dismissal of a lawsuit brought by insurers who say they don't have to defend the private equity firm in product liability lawsuits related to contamination of the blood thinner heparin.
Friday's motion in the U.S. District Court for the District of Maryland says that the "concerns of judicial economy cry out for the granting of this motion," which if granted would force two insurers — subsidiaries of insurance giant The Travelers Cos. Inc. — to provide a defense in dozens...
Travelers Must Fund Heparin Defense: Equity Firm
To view the full article, take a free trial now.
